Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junmin Song

Showing results (81-90 of 95) with videos related to

Pageof 10
Sort By:
European Journal of Cancer (Oxford, England : 1990)|December 22, 2024
Glucagon-like Peptide-1 Agonists Reduce Cardiovascular Events in Cancer Patients on Immune Checkpoint InhibitorsCho-Han Chiang, Junmin Song, Kuan-Yu Chi, et al.
Gastroenterology|June 11, 2025
Glucagon-like peptide-1 Receptor Agonists and Gastrointestinal Adverse Events: a Systematic Review and Meta-analysisCho-Hung Chiang, Aunchalee Jaroenlapnopparat, Sena Cakir Colak, et al.
European Journal of Preventive Cardiology|September 19, 2024
Beta-blockers for secondary prevention following myocardial infarction in patients without reduced ejection fraction or heart failure: an updated meta-analysisKuan-Yu Chi, Pei-Lun Lee, Ishmum Chowdhury, et al.
The International Journal of Social Psychiatry|December 13, 2022
The association of physical multimorbidity with suicidal ideation and suicide attempts in England: A mediation analysis of influential factorsLee Smith, Jae Il Shin, San Lee, et al.
JACC. Heart Failure|May 7, 2025
Sodium-Glucose Cotransporter 2 Inhibitors in Tafamidis-Treated Transthyretin Amyloid Cardiomyopathy: A Contemporary Real-World AnalysisKuan-Yu Chi, Dimitrios Varrias, Pawel Borkowski, et al.
Blood Advances|February 5, 2025
Glucagon-like peptide 1 receptor agonists and venous thromboembolism in type 2 diabetes: a target trial emulationCho-Han Chiang, Junmin Song, Yu-Cheng Chang, et al.
Journal of Thrombosis and Haemostasis : JTH|July 2, 2025
Glucagon-like peptide 1 receptor agonists and risk of venous thromboembolism: a systematic review and meta-analysis of randomized controlled trialsCho-Han Chiang, Yu-Cheng Chang, Chun-Chiao Yu, et al.
Annals of Internal Medicine|December 8, 2025
Risk for Cancer With Glucagon-Like Peptide-1 Receptor Agonists and Dual Agonists : A Systematic Review and Meta-analysisAlbert Ko, Yu-Cheng Chang, Furkan Bahar, et al.
Journal of Clinical Biochemistry and Nutrition|March 26, 2013
Apurinic/apyrimidinic endonuclease-1 (APE-1) is overexpressed via the activation of NF-κB-p65 in MCP-1-positive esophageal squamous cell carcinoma tissueJunmin Song, Seiji Futagami, Hiroyuki Nagoya, et al.
JAMA Network Open|June 30, 2025
GLP-1 RA Use and Major Adverse Cardiovascular Events in Patients With Monoclonal Gammopathy of Undetermined SignificanceKuan-Yu Chi, Junmin Song, Shweta Desphande, et al.
Pageof 10

Showing results (81-90 of 95) with videos related to

Sort By:
Pageof 10
European Journal of Cancer (Oxford, England : 1990)|December 22, 2024
Glucagon-like Peptide-1 Agonists Reduce Cardiovascular Events in Cancer Patients on Immune Checkpoint InhibitorsCho-Han Chiang, Junmin Song, Kuan-Yu Chi, et al.
Gastroenterology|June 11, 2025
Glucagon-like peptide-1 Receptor Agonists and Gastrointestinal Adverse Events: a Systematic Review and Meta-analysisCho-Hung Chiang, Aunchalee Jaroenlapnopparat, Sena Cakir Colak, et al.
European Journal of Preventive Cardiology|September 19, 2024
Beta-blockers for secondary prevention following myocardial infarction in patients without reduced ejection fraction or heart failure: an updated meta-analysisKuan-Yu Chi, Pei-Lun Lee, Ishmum Chowdhury, et al.
The International Journal of Social Psychiatry|December 13, 2022
The association of physical multimorbidity with suicidal ideation and suicide attempts in England: A mediation analysis of influential factorsLee Smith, Jae Il Shin, San Lee, et al.
JACC. Heart Failure|May 7, 2025
Sodium-Glucose Cotransporter 2 Inhibitors in Tafamidis-Treated Transthyretin Amyloid Cardiomyopathy: A Contemporary Real-World AnalysisKuan-Yu Chi, Dimitrios Varrias, Pawel Borkowski, et al.
Blood Advances|February 5, 2025
Glucagon-like peptide 1 receptor agonists and venous thromboembolism in type 2 diabetes: a target trial emulationCho-Han Chiang, Junmin Song, Yu-Cheng Chang, et al.
Journal of Thrombosis and Haemostasis : JTH|July 2, 2025
Glucagon-like peptide 1 receptor agonists and risk of venous thromboembolism: a systematic review and meta-analysis of randomized controlled trialsCho-Han Chiang, Yu-Cheng Chang, Chun-Chiao Yu, et al.
Annals of Internal Medicine|December 8, 2025
Risk for Cancer With Glucagon-Like Peptide-1 Receptor Agonists and Dual Agonists : A Systematic Review and Meta-analysisAlbert Ko, Yu-Cheng Chang, Furkan Bahar, et al.
Journal of Clinical Biochemistry and Nutrition|March 26, 2013
Apurinic/apyrimidinic endonuclease-1 (APE-1) is overexpressed via the activation of NF-κB-p65 in MCP-1-positive esophageal squamous cell carcinoma tissueJunmin Song, Seiji Futagami, Hiroyuki Nagoya, et al.
JAMA Network Open|June 30, 2025
GLP-1 RA Use and Major Adverse Cardiovascular Events in Patients With Monoclonal Gammopathy of Undetermined SignificanceKuan-Yu Chi, Junmin Song, Shweta Desphande, et al.
Pageof 10